Search

Search Results

• Application of ChatGPT as a content generation tool in continuing medical education: acne as a test topic

  Luigi Naldi, Vincenzo Bettoli, Eugenio Santoro, Maria Rosa Valetto, Anna Bolzon, Fortunato Cassalia, Simone Cazzaniga, Sergio Cima, Andrea Danese, Silvia Emendi, Monica Ponzano, Nicoletta Scarpa, Pietro Dri

  28-11-2024

  https://doi.org/10.4081/dr.2024.10138

  1190

  PDF: 662

  SUPPLEMENTARY MATERIAL: 126

  HTML: 18
• 

  Agreement on classification of clinical photographs of pigmentary lesions: exercise after a training course with young dermatologists

  Simone Cazzaniga, Lucia De Ponti, Giorgio Maria Baratelli, Salvatore Francione, Carlo La Vecchia, Anna Di Landro, Andrea Carugno, Marco Di Mercurio, Lerica Germi, Giampaolo Trevisan, Mirko Fenaroli, Claudia Capasso, Michele Pezza, Pietro Dri, Emanuele Castelli, Luigi Naldi

  14-07-2022

  https://doi.org/10.4081/dr.2022.9500

  1124

  PDF: 434

  HTML: 18
• 

  Fifteen years of melanomatous meetings

  Antonio Perasole, Cesare Massone

  30-03-2022

  https://doi.org/10.4081/dr.2022.9502

  2278

  PDF: 465

  HTML: 19

• Is ChatGPT a reliable informant? Dermatologists review AI-generated answers to frequently asked questions about melanoma

  Gianluca Pistore, Luca Fania, Giovanni Pellacani, Ignazio Stanganelli, Giovanni Paolino, Cesare Massone, Giovanni Di Lella, Damiano Abeni, Francesco Ricci

  21-01-2026

  https://doi.org/10.4081/dr.2026.10568

  383

  PDF: 194

• Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

  Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

  11-09-2023

  https://doi.org/10.4081/dr.2023.9824

  884

  PDF: 543

  HTML: 32
• 

  09 | Integration of hematoxylin and eosin and immunohistochemistry images to improve AI-based recurrence prediction in negative sentinel lymphnode melanoma patients Maria Colomba Comes¹, Andrea Lupo¹, Fabio Mele², Concetta Saponaro², Arianna Bozzi¹, Ivana De Risi³, Samantha Bove¹, Annarita Fanizzi¹, Benedetta Apollonio³, Margherita Sonnessa², Sabino Strippoli³, Francesco Alfredo Zito², Michele Guida³, Raffaella Massafra¹ | ¹Biostatistics and Bioinformatics Unit, IRCCS Istituto Tumori "Giovanni Paolo II"; ²Pathology Unit, IRCCS Istituto Tumori "Giovanni Paolo II"; ³Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10751

  316